Unraveling the genetics of common epilepsies: Approaches, platforms, and caveats

Epilepsy and Behavior

Volumn 26, Issue 3, 2013, Pages 229-233

  Petrovski, Slavé ^a,b   Kwan, Patrick ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epigenetics; Epilepsy; Exome; Genome; GWAS; Pathway analysis; Sequencing; Structural variants

Indexed keywords

ANTICONVULSANT THERAPY; CHINESE; COPY NUMBER VARIATION; DISEASE PREDISPOSITION; DNA METHYLATION; EPILEPSY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; GENOTYPE; HIGH RISK PATIENT; HIGH THROUGHPUT SEQUENCING; HUMAN; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; EPIGENOMICS; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MODELS, BIOLOGICAL;

EID: 84875241913     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.09.007     Document Type: Review

References (56)

1. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342(5):314-319.
2. Kasperaviciute D., Catarino C.B., Heinzen E.L., et al. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain 2010, 133(Pt 7):2136-2147.
3. Guo Y., Baum L.W., Sham P.C., et al. Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. Hum Mol Genet 2012, 21(5):1184-1189.
4. Consortium E, Consortium EM, Steffens M, et al. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet in press.
5. Manolio T.A., Collins F.S., Cox N.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753.
6. Mulley J.C., Scheffer I.E., Harkin L.A., Berkovic S.F., Dibbens L.M. Susceptibility genes for complex epilepsy. Hum Mol Genet 2005, 14(2):R243-R249.
7. Fisher R.S., van Emde Boas W., Blume W., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46(4):470-472.
8. Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
9. Berkovic S.F., Howell R.A., Hay D.A., Hopper J.L. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998, 43(4):435-445.
10. Kjeldsen M.J., Kyvik K.O., Christensen K., Friis M.L. Genetic and environmental factors in epilepsy: a population-based study of 11900 Danish twin pairs. Epilepsy Res 2001, 44(2-3):167-178.
11. Miller L.L., Pellock J.M., DeLorenzo R.J., Meyer J.M., Corey L.A. Univariate genetic analyses of epilepsy and seizures in a population-based twin study: the Virginia Twin Registry. Genet Epidemiol 1998, 15(1):33-49.
12. Kjeldsen M.J., Corey L.A., Christensen K., Friis M.L. Epileptic seizures and syndromes in twins: the importance of genetic factors. Epilepsy Res 2003, 55(1-2):137-146.
13. Berkovic S.F., Mulley J.C., Scheffer I.E., Petrou S. Human epilepsies: interaction of genetic and acquired factors. Trends Neurosci 2006, 29(7):391-397.
14. Crino P.B. Gene expression, genetics, and genomics in epilepsy: some answers, more questions. Epilepsia 2007, 48(Suppl. 2):42-50.
15. Petrovski S., Szoeke C.E., Jones N.C., et al. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology 2010, 75(11):1015-1021.
16. Christensen J., Pedersen M.G., Pedersen C.B., Sidenius P., Olsen J., Vestergaard M. Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study. Lancet 2009, 373(9669):1105-1110.
17. McKhann G.M., Wenzel H.J., Robbins C.A., Sosunov A.A., Schwartzkroin P.A. Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience 2003, 122(2):551-561.
18. Berkovic S.F., Scheffer I.E. Genetics of the epilepsies. Epilepsia 2001, 42(Suppl. 5):16-23.
19. Diaz-Arrastia R., Gong Y., Fair S., et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol 2003, 60(6):818-822.
20. Cavalleri G.L., Weale M.E., Shianna K.V., et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol 2007, 6(11):970-980.
21. Helbig I., Scheffer I.E., Mulley J.C., Berkovic S.F. Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol 2008, 7(3):231-245.
22. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11(6):415-425.
23. de Kovel C.G., Trucks H., Helbig I., et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010, 133(Pt 1):23-32.
24. Dibbens L.M., Mullen S., Helbig I., et al. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet 2009, 18(19):3626-3631.
25. Helbig I., Mefford H.C., Sharp A.J., et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009, 41(2):160-162.
26. Heinzen E.L., Radtke R.A., Urban T.J., et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 2010, 86(5):707-718.
27. Vineis P., Pearce N. Missing heritability in genome-wide association study research. Nat Rev Genet 2010, 11(8):589.
28. Heinzen E.L., Swoboda K.J., Hitomi Y., et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 2012, 44(9):1030-1034.
29. The Epi KC Epi4K: gene discovery in 4,000 genomes. Epilepsia 2012, 53(8):1457-1467.
30. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science 2001, 291(5507):1304-1351.
31. Consortium E.P., Bernstein B.E., Birney E., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489(7414):57-74.
32. Kiezun A., Garimella K., Do R., et al. Exome sequencing and the genetic basis of complex traits. Nat Genet 2012, 44(6):623-630.
33. Heijmans B.T., Tobi E.W., Stein A.D., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 2008, 105(44):17046-17049.
34. Bell J.T., Spector T.D. A twin approach to unraveling epigenetics. Trends Genet 2011, 27(3):116-125.
35. Stankiewicz P., Lupski J.R. Structural variation in the human genome and its role in disease. Annu Rev Med 2010, 61:437-455.
36. Erez A., Patel A.J., Wang X., et al. Alu-specific microhomology-mediated deletions in CDKL5 in females with early-onset seizure disorder. Neurogenetics 2009, 10(4):363-369.
37. Eichler E.E. Copy number variation and human disease. Nat Educ 2008, 1(3).
38. Wellcome Trust Case Control C, Craddock N., Hurles M.E., et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010, 464(7289):713-720.
39. Lubin F.D. Epileptogenesis: can the science of epigenetics give us answers?. Epilepsy Curr/ Am Epilepsy Soc 2012, 12(3):105-110.
40. Milutinovic S., D'Alessio A.C., Detich N., Szyf M. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 2007, 28(3):560-571.
41. Shen L., Waterland R.A. Methods of DNA methylation analysis. Curr Opin Clin Nutr Metab Care 2007, 10(5):576-581.
42. Weeks K.M. Advances in RNA structure analysis by chemical probing. Curr Opin Struct Biol 2010, 20(3):295-304.
43. Wan Y., Kertesz M., Spitale R.C., Segal E., Chang H.Y. Understanding the transcriptome through RNA structure. Nat Rev Genet 2011, 12(9):641-655.
44. Rakyan V.K., Down T.A., Balding D.J., Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011, 12(8):529-541.
45. Morris A.P. Transethnic meta-analysis of genomewide association studies. Genet Epidemiol 2011, 35(8):809-822.
46. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet 1993, 9(4):138-141.
47. Evans D.M., Spencer C.C., Pointon J.J., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011, 43(8):761-767.
48. Lage K., Karlberg E.O., Storling Z.M., et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 2007, 25(3):309-316.
49. Holmans P., Green E.K., Pahwa J.S., et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 2009, 85(1):13-24.
50. Warde-Farley D., Donaldson S.L., Comes O., et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010, 38(Web Server issue):W214-W220.
51. Rossin E.J., Lage K., Raychaudhuri S., et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 2011, 7(1):e1001273.
52. Iossifov I., Ronemus M., Levy D., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74(2):285-299.
53. Neale B.M., Kou Y., Liu L., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485(7397):242-245.
54. O'Roak B.J., Vives L., Girirajan S., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485(7397):246-250.
55. Baulac M., Pitkanen A. Research priorities in epilepsy for the next decade - a representative view of the European scientific community. Epilepsia 2008, 50(3):571-578.
56. Kelley M.S., Jacobs M.P., Lowenstein D.H., Stewards N.E.B. The NINDS epilepsy research benchmarks. Epilepsia 2009, 50(3):579-582.